Legis Daily

A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.

USA115th CongressS-1882| Senate 
| Updated: 9/28/2017
Edward J. Markey

Edward J. Markey

Democratic Senator

Massachusetts

Cosponsors (5)
Jeanne Shaheen (Democratic)Margaret Wood Hassan (Democratic)Richard J. Durbin (Democratic)Joe Manchin (Independent)Sherrod Brown (Democratic)

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Opioid Quota Openness, Transparency, and Awareness Act of 2017 or the Opioid QuOTA Act This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to publish on its website certain information with respect to a registered manufacturer’s opioid procurement quota. It defines the term "opioid procurement quota" as a quota established by the DEA for the quantity of opioid analgesics that a registered manufacturer may procure.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 28, 2017
Introduced in Senate
Sep 28, 2017
Read twice and referred to the Committee on the Judiciary.
  • September 28, 2017
    Introduced in Senate


  • September 28, 2017
    Read twice and referred to the Committee on the Judiciary.

Crime and Law Enforcement

Congressional oversightDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsLicensing and registrations

A bill to amend the Controlled Substances Act to require the Attorney General to make procurement quotas for opioid analgesics publicly available, and for other purposes.

USA115th CongressS-1882| Senate 
| Updated: 9/28/2017
Opioid Quota Openness, Transparency, and Awareness Act of 2017 or the Opioid QuOTA Act This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to publish on its website certain information with respect to a registered manufacturer’s opioid procurement quota. It defines the term "opioid procurement quota" as a quota established by the DEA for the quantity of opioid analgesics that a registered manufacturer may procure.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 28, 2017
Introduced in Senate
Sep 28, 2017
Read twice and referred to the Committee on the Judiciary.
  • September 28, 2017
    Introduced in Senate


  • September 28, 2017
    Read twice and referred to the Committee on the Judiciary.
Edward J. Markey

Edward J. Markey

Democratic Senator

Massachusetts

Cosponsors (5)
Jeanne Shaheen (Democratic)Margaret Wood Hassan (Democratic)Richard J. Durbin (Democratic)Joe Manchin (Independent)Sherrod Brown (Democratic)

Judiciary Committee

Crime and Law Enforcement

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Congressional oversightDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsLicensing and registrations